VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus

World Journal of Surgery

Volumn 31, Issue 9, 2007, Pages 1768-1772

  Möbius, Christian ^a   Freire, José ^b   Becker, Ingrid ^c   Feith, Marcus ^c   Brücher, Björn L D M ^c   Hennig, Michael ^c   Siewert, J Rüdiger ^c   Stein, Hubert J ^d,e  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d University Hospital Salzburg   (Austria)

^e University Hospital Salzburg ^*  (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PARAFFIN; VASCULOTROPIN C;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS TUMOR; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TUMOR GROWTH;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 34548013055     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-006-0373-1     Document Type: Article

References (13)

1. Siewert JR, Feith M, Werner M, et al. Adenocarcinoma of the esophagogastric junction. Results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 2000;232:353-361
2. Siewert JR, Stein HJ, Feith M, et al. Histologic tumour type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 2001;234:360-369
3. Natsugoe S, Stein HJ, Mueller J, et al. Micrometastasis and tumor cell microinvolvement of lymph nodes esophageal squamous cell cancer: frequency, associated tumor characteristics and impact on prognosis. Cancer 1998;83:858-866
4. Mueller JD, Stein HJ, Oyang T, et al. Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction. Cancer 2000;89:1874-1882
5. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. Mol Med 1999;77:527-543
6. Karkkainen MJ, Petrova TV. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 2000;19:5598-5605
7. Yonemura Y, Fushida S, Bando E, et al. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer. Eur J Cancer 2001;37:918-923
8. Kajita T, Ohta Y, Kinura K, et al. The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer. Br J Cancer 2001;85:255-260
9. Wittekind C, Compton CC, Greene FL, et al. TNM residual tumor classification revisited. Cancer 2002;94:2511-2516
10. Karpanem T, Egeblad M, Karkkainen J, et al. Vascular endothelial growth factor C promotes tumour lymphangiogenesis and intralymphatic tumour growth. Cancer Res 2001;61:1786-1790
11. Kukk E, Lymboussaki A, Taira S, et al. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in the lymphatic vascular development. Development (Camb) 1996;122:3829-3837
12. Kitadai Y, Amioka T, Haruma K, et al. Clinicopathological significance of vascular endothelial growth factor (VEGF)- C in human esophageal squamous cell carcinomas. Int J Cancer 2001;93:662-666
13. Noguchi T, Takeno S, Shibata T, et al. VEGF-C expression correlates with histological differentiation and metastasis in squamous cell carcinoma of the esophagus. Oncol Rep 2002;9:995-999